Table 6.

Follow-up on enrolled patients during the COVID-19 pandemic

	Tumor Compression	CIPN	Postsurgical	Postradiation	Total
Total number of patients	n = 2	n = 9	n = 3	n = 0	N = 14
Responders, n (%)	2 (100.0)	7 (77.8)	2 (66.7)	0	11 (78.6)
Duration of relief, n (%)
<2 weeks	0	2 (22.2)	1 (33.3)	0	3 (21.4)
2–3 weeks	1 (50.0)	1 (11.1)	0	0	2 (14.3)
≥3 weeks	1 (50.0)	6 (66.7)	2 (66.7)	0	9 (64.3)
Adverse events, n (%)
Gastrointestinal (nausea, vomiting)	1 (50.0)	1 (11.1)	0	0	2 (14.3)
Neurological (headache, somnolence)	1 (50.0)	1 (11.1)	1 (33.3)	0	3 (21.4)
Psychiatric (hallucinations)	0	1 (11.1)	0	0	1 (7.1)
None	0	6 (66.7)	2 (66.7)	0	8 (57.1)
Pain medication changes, n (%)
Opioids	1 (50.0)	3 (33.3)	0	0	4 (30.8)
Gabapentinoids	0	2 (22.2)	0	0	2 (15.4)
Cannabis	0	1 (11.1)	1 (50.0)	0	2 (15.4)
No change	1 (50.0)	3 (33.3)	1 (50.0)	0	5 (38.5)

“Pain medication changes” refers to medication changes in the 13 patients whose pain returned to baseline.